Quidel Corporation operates in the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Quidel with three other
companies in this sector in the United States:
Trinity Biotech PLC
sales of $100.20 million
of which 73%
was Clinical Laboratory),
of which 54%
was Animal Safety), and
Meridian Bioscience, Inc.
of which 75%
was US Diagnostics).
Quidel reported sales of $196.13 million
December of 2015.
increase of 7.4%
versus 2014, when the company's sales were $182.62 million.
This was the third consecutive year of growth at Quidel.